Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Travere Therapeutics, Inc.

TVTX · Nasdaq · CIK 0001438533 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

112 Form 4 transaction lines observed in the same window
64 sales · 48 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
○▼○▼○▼
Dube Eric MCHIEF EXECUTIVE OFFICER
○▼○▼○▼
LYONS GARY ADirector
○○▼○▼
ROTE WILLIAM E.Chief Research Officer
○▼○▼
Inrig JulaEVP, Head of R&D & CMO
○○▼
Coughlin TimothyDirector
○○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 10 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
121Sales
95Other Form 4 lines
72SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING64 sale line(s) · context only
OTHER48 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
12,655,839
Previous report
12,955,933
Avg daily volume
1,751,519
Days to cover
7.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

216 transaction lines in the latest 365-day window; 635 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17Heerma PeterSale (S)Common Stock8,282USD 65.07USD 538,910SEC filing ↗
2026-09-17Heerma PeterOption exercise / conversion (M)Common Stock8,282USD 22.40USD 185,517SEC filing ↗
2026-09-17Dube Eric MSale (S)Common Stock108,493USD 64.61USD 7,010,012SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17Heerma PeterSale (S)Common Stock8,282USD 65.07USD 538,910SEC filing ↗
2026-09-17Heerma PeterOption exercise / conversion (M)Common Stock8,282USD 22.40USD 185,517SEC filing ↗
2026-09-17Dube Eric MSale (S)Common Stock108,493USD 64.61USD 7,010,012SEC filing ↗
2026-09-17Dube Eric MOption exercise / conversion (M)Common Stock108,493USD 23.34USD 2,532,227SEC filing ↗
2026-09-16ROTE WILLIAM E.Sale (S)Common Stock112,850USD 63.33USD 7,146,488SEC filing ↗
2026-09-16ROTE WILLIAM E.Option exercise / conversion (M)Common Stock112,850USD 21.29USD 2,402,186SEC filing ↗
2026-09-16Heerma PeterSale (S)Common Stock172,717USD 63.43USD 10,955,995SEC filing ↗
2026-09-16Heerma PeterOption exercise / conversion (M)Common Stock172,717USD 14.19USD 2,451,533SEC filing ↗
2026-09-16Dube Eric MSale (S)Common Stock195,841USD 63.45USD 12,425,429SEC filing ↗
2026-09-16Dube Eric MOption exercise / conversion (M)Common Stock195,841USD 23.34USD 4,570,929SEC filing ↗
2026-09-15ROTE WILLIAM E.Sale (S)Common Stock96,198USD 62.25USD 5,988,634SEC filing ↗
2026-09-15ROTE WILLIAM E.Option exercise / conversion (M)Common Stock78,650USD 21.57USD 1,696,864SEC filing ↗
2026-09-15REED ELIZABETH ESale (S)Common Stock37,500USD 62.34USD 2,337,757SEC filing ↗
2026-09-15REED ELIZABETH EOption exercise / conversion (M)Common Stock37,500USD 15.46USD 579,750SEC filing ↗
2026-09-15Inrig JulaSale (S)Common Stock44,674USD 62.34USD 2,785,040SEC filing ↗
2026-09-15Inrig JulaOption exercise / conversion (M)Common Stock32,395USD 8.93USD 289,287SEC filing ↗
2026-09-15Heerma PeterSale (S)Common Stock102,190USD 62.26USD 6,362,602SEC filing ↗
2026-09-15Heerma PeterOption exercise / conversion (M)Common Stock77,190USD 18.31USD 1,413,039SEC filing ↗
2026-09-15Dube Eric MSale (S)Common Stock95,666USD 62.25USD 5,955,643SEC filing ↗
2026-09-15Dube Eric MOption exercise / conversion (M)Common Stock95,666USD 23.34USD 2,232,844SEC filing ↗
2026-09-15Cline Christopher R.Sale (S)Common Stock50,508USD 62.34USD 3,148,679SEC filing ↗
2026-09-15Cline Christopher R.Option exercise / conversion (M)Common Stock20,000USD 17.44USD 348,800SEC filing ↗
2026-09-15Calvin SandraSale (S)Common Stock5,375USD 62.33USD 335,026SEC filing ↗
2026-09-15Calvin SandraOption exercise / conversion (M)Common Stock5,375USD 24.19USD 129,998SEC filing ↗
2026-09-10Meckler Jeffrey ASale (S)Common Stock20,000USD 67.30USD 1,346,062SEC filing ↗
2026-09-10Meckler Jeffrey AOption exercise / conversion (M)Common Stock20,000USD 21.98USD 439,600SEC filing ↗
2026-09-02Cline Christopher R.Sale (S)Common Stock642USD 66.37USD 42,610SEC filing ↗
2026-08-18LYONS GARY ASale (S)Common Stock5,000USD 63.38USD 316,881SEC filing ↗
2026-08-18LYONS GARY AOption exercise / conversion (M)Common Stock5,000USD 17.44USD 87,200SEC filing ↗
2026-08-17LYONS GARY ASale (S)Common Stock5,000USD 63.20USD 315,987SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTVTX
CIK0001438533
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history635 transaction lines from 2020-01-07 to 2026-09-17
0 P purchase lines · 370 S sale lines · 265 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.